Leveraging Preclinical Tumor Models to Aid Targeted Cytokine Therapy
Time: 1:30 pm
day: Day One PM - Track 2
Details:
- Understanding the rationale behind choosing the tumor models in this study
- Evaluating tumor efficacy and toxicity in mouse models to assess tumor response to treatment
- Combination dosing strategies of the IL-2 variant with bispecifics and CAR-T therapies
